Abingdon Health (LON:ABDX) Stock Price Up 6.1% – What’s Next?

Shares of Abingdon Health Plc (LON:ABDX) rose 6.1% during mid-day trading on Wednesday . The company traded as high as GBX 8.49 and last traded at GBX 8.49. Approximately 204 shares were traded during trading, a decline of 100% from the average daily volume of 185,072 shares. The stock had previously closed at GBX 8.

Abingdon Health Stock Up 6.1%

The company has a current ratio of 1.91, a quick ratio of 1.96 and a debt-to-equity ratio of 15.05. The stock has a 50-day simple moving average of GBX 7.12 and a 200-day simple moving average of GBX 6.71. The company has a market cap of £21.32 million, a price-to-earnings ratio of -10.48 and a beta of 0.25.

Abingdon Health (LON:ABDX) last announced its quarterly earnings results on Tuesday, March 17th. The company reported GBX (0.43) earnings per share (EPS) for the quarter. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.